← Back to Search

Procedure

Half A of the FTSG for Skin Graft Scar

N/A
Recruiting
Led By Victoria R Sharon, MD
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients 18 years or older
Patients undergoing FTSG reconstruction at any body site to close a primary defect after dermatologic surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial is testing if using running epidermal sutures in skin graft placement is as good as using simple interrupted sutures for patients having dermatologic surgery. The study will split each participant's scar

Who is the study for?
This trial is for patients who are getting a full-thickness skin graft as part of dermatologic surgery, like Mohs micrographic surgery or excision. The study will compare the cosmetic outcomes of two different suturing techniques on their scars.Check my eligibility
What is being tested?
The trial is testing if running epidermal sutures give similar or better cosmetic results compared to simple interrupted sutures in skin grafts. Each participant's scar will be split; one half gets running sutures and the other half gets interrupted ones, with results checked after 3 months.See study design
What are the potential side effects?
Potential side effects may include differences in scar appearance, discomfort at the suture site, possible infection risk, and varying healing times between the two methods.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am having a skin graft to close a wound after skin surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The Patient and Observer Scar Assessment Scale (POSAS)
Secondary outcome measures
Clinician overall opinion
Complications
Patient overall opinion

Trial Design

2Treatment groups
Active Control
Group I: Half A of the FTSGActive Control2 Interventions
"A" (superior or left relative to the patient, depending on the shape of the wound)
Group II: Half B of the FTSGActive Control2 Interventions
"B" (inferior or right relative to the patient).

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
460 Previous Clinical Trials
470,991 Total Patients Enrolled
Victoria R Sharon, MDPrincipal InvestigatorNorthwell Dermatology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to apply and participate in this ongoing medical trial?

"Indeed, clinicaltrials.gov verifies that this clinical trial is currently seeking candidates. The initial posting took place on August 1st, 2023, with the most recent update occurring on January 22nd, 2024."

Answered by AI

How many participants in total are involved in this particular research endeavor?

"Indeed, the information available on clinicaltrials.gov confirms that this trial is actively seeking participants. It was initially posted on August 1st, 2023 and last updated on January 22nd, 2024. The study aims to enroll a total of 52 patients at a single site."

Answered by AI
~13 spots leftby Aug 2024